BSE Live
Dec 08, 16:01Prev. Close
170.15
Open Price
169.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 08, 15:31Prev. Close
170.18
Open Price
170.18
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
164.64 (3)
| Cash Flow of Suven Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -160.75 | -106.08 | -118.27 | -122.00 | -77.47 | |
| Net CashFlow From Operating Activities | -154.10 | -115.47 | -103.15 | -127.54 | -96.02 | |
| Net Cash Used In Investing Activities | 154.95 | 94.44 | -260.65 | -22.23 | 55.84 | |
| Net Cash Used From Financing Activities | -0.76 | -1.05 | 395.54 | 145.69 | 34.86 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.09 | -22.09 | 31.75 | -4.07 | -5.33 | |
| Cash And Cash Equivalents Begin of Year | 14.93 | 37.02 | 5.27 | 9.35 | 14.68 | |
| Cash And Cash Equivalents End Of Year | 15.03 | 14.93 | 37.02 | 5.27 | 9.35 |
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y